ClinVar Miner

Submissions for variant NM_001130987.2(DYSF):c.3695C>T (p.Pro1232Leu)

gnomAD frequency: 0.00020  dbSNP: rs150942486
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000727399 SCV000621754 uncertain significance not provided 2017-10-25 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the DYSF gene. The P1214L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The P1214L variant is observed in 31/30780 (0.1%) alleles from individuals of South Asian background (Lek et al., 2016). The P1214L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved in mammals; and in silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Eurofins Ntd Llc (ga) RCV000727399 SCV000708226 uncertain significance not provided 2017-05-05 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000727399 SCV000892567 uncertain significance not provided 2018-05-01 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000765698 SCV000897040 uncertain significance Miyoshi muscular dystrophy 1; Autosomal recessive limb-girdle muscular dystrophy type 2B; Distal myopathy with anterior tibial onset 2018-10-31 criteria provided, single submitter clinical testing
Invitae RCV001485096 SCV001689523 likely benign Qualitative or quantitative defects of dysferlin 2024-01-16 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001563734 SCV001786739 uncertain significance Miyoshi muscular dystrophy 1 2021-07-14 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001272834 SCV001786740 uncertain significance Autosomal recessive limb-girdle muscular dystrophy type 2B 2021-07-14 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001563735 SCV001786741 uncertain significance Distal myopathy with anterior tibial onset 2021-07-14 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000727399 SCV003831270 uncertain significance not provided 2022-07-14 criteria provided, single submitter clinical testing
Natera, Inc. RCV001272834 SCV001455225 uncertain significance Autosomal recessive limb-girdle muscular dystrophy type 2B 2019-11-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.